Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience
SARS-CoV-2 감염 신장 이식 환자: Brescia Renal COVID 태스크포스 경험
Multicenter Study
[키워드] Acute kidney injury
acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
addition
Admission
age
antiviral drugs
ARDS
average
Azithromycin
baseline
Brescia
C-reactive protein
Clinical characteristics
clinical research/practice
Cohort
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID
COVID-19
D-dimer
death
Dexamethasone
died
disease
Dyspnea
higher risk
Hydroxychloroquine
Immunosuppression
increased risk
Infection
infection and infectious agents - viral
infectious
infectious agent
infectious agents
Infectious disease
kidney
Kidney disease
kidney disease: infectious.
kidney transplant
lack
lymphopenia
Methylprednisolone
Mild
Mild disease
Older
outcome
Outpatient
outpatients
Patient
patients
patients with SARS-CoV-2
reduction
renal
required
respiratory
respiratory distress
Respiratory distress syndrome
risk
risk factor
Risk factors
risk of death
SARS-CoV-2
SARS-COV-2 infection
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe symptoms
syndrome
tacrolimus
the patient
thrombocytopenia
Tocilizumab
Withdrawal
[DOI] 10.1111/ajt.16176 PMC 바로가기 [Article Type] Multicenter Study
[DOI] 10.1111/ajt.16176 PMC 바로가기 [Article Type] Multicenter Study